Related Experiment Video
Updated: Jul 3, 2026

10:05
DTI of the Visual Pathway - White Matter Tracts and Cerebral Lesions
Published on: August 26, 2014
Selective diffusion changes of the visual pathways in patients with migraine: a 3-T tractography study
M A Rocca1, E Pagani, B Colombo
1Neuroimaging Research Unit, Department of Neurology, University Ospedale San Raffaele, Milan, Italy.
Cephalalgia : an International Journal of Headache
|July 23, 2008
Summary
Migraine with aura (MA) patients show structural changes in the optic radiation (OR) compared to controls and migraine without aura (MoA) patients. These optic radiation alterations may serve as a biomarker for migraine with aura.
Area of Science:
- Neuroscience
- Radiology
- Ophthalmology
Background:
- Migraine is a common neurological disorder.
- Migraine with aura (MA) is associated with visual disturbances.
- Structural brain changes in MA are not fully understood.
Purpose of the Study:
- To investigate optic radiation (OR) structural integrity in MA patients.
- To compare OR metrics between MA, migraine without aura (MoA), and control groups.
- To explore correlations between OR changes, clinical features, and MRI findings.
Main Methods:
- Diffusion tensor tractography (DTT) was used to analyze white matter (WM) structure.
- Fractional anisotropy (FA) and mean diffusivity (MD) of the OR were quantified.
- Corticospinal tract and corpus callosum served as control WM tracts.
Main Results:
- MA patients exhibited reduced OR fractional anisotropy (FA) compared to controls and MoA patients.
- Higher right OR mean diffusivity (MD) was observed in MA patients versus controls.
- No significant correlations were found between OR metrics and clinical or MRI data.
Conclusions:
- Diffusion tensor tractography reveals distinct structural alterations in the optic radiation of MA patients.
- These OR changes may represent a potential phenotypic biomarker for migraine with aura.
- The findings suggest that OR changes are intrinsic to MA and not solely related to clinical presentation or T2-visible lesions.

